CD81 Aggravates Ovarian Cancer Progression via p‐Cresyl Sulfate‐Mediated Mitophagy in Tim4 + Tumour‐Associated Macrophages
Journal of Cellular and Molecular Medicine · 2025-07 · 29 (13)
DOI: 10.1111/jcmm.70701 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 02.07.2025. Verfasst von Jiali Ni und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology, The State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Mitophagy, Tumor-Associated Macrophages, Tetraspanin 28. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Innovative Training Program for Undergraduates of Nanjing University.
Abstract (Originalsprache)
Ovarian cancer (OC) is characterised by widespread peritoneal metastasis. Tetraspanin CD81 is predominantly located at the cellular membrane and exhibits inconsistent roles in tumour progression. However, its precise function in OC remains unclear. We found that CD81 expression was significantly elevated in tumour tissues from OC patients with poor prognosis, and it directly promoted proliferation, and migration of OC cells. Stable knock‐down of CD81 expression ameliorated disease progression in a murine model of OC and induced metabolic responses in OC cells. Metabolomics and mass spectrometry identified the protein‐bound toxin p‐cresyl sulfate (PCS) as a key metabolite regulated by the CD81‐FAK signalling axis. One aspect is that PCS promoted the growth of OC cells. Furthermore, tumour‐derived PCS combined with Cdh1 to enhance Bnip3‐dependent mitophagy activity of Tim4 positive tumour‐associated macrophages (TAMs). Intraperitoneal injection of PCS reversed the therapeutic effects observed following CD81 knock‐down; the mitophagy of reprogrammed Tim4 + TAMs was also promoted, accompanied by alterations in antitumor immunity. In summary, we elucidated CD81 prompted Tim4 + TAMs mitophagy to induce OC progression via FAK/PCS/Cdh1 pathway, deepen our understanding of OC pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Immunology, The State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing University, Nanjing, China.
- Jiangsu Key Laboratory of Molecular Medicine, Nanjing, China.
- School of Life Science and Technology, The Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing, China.
- General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Förderung
- National Natural Science Foundation of China
- Innovative Training Program for Undergraduates of Nanjing University
Zitieren
APA
Ni, J., Li, X., Wu, Y., Tu, X., Zhang, X., Wang, L., Xie, H., Hou, Y., Dou, H., & Zhao, S. (2025). CD81 Aggravates Ovarian Cancer Progression via p‐Cresyl Sulfate‐Mediated Mitophagy in Tim4 + Tumour‐Associated Macrophages. Journal of Cellular and Molecular Medicine, 29(13). https://doi.org/10.1111/jcmm.70701
Vancouver
Ni J, Li X, Wu Y, Tu X, Zhang X, Wang L, et al. CD81 Aggravates Ovarian Cancer Progression via p‐Cresyl Sulfate‐Mediated Mitophagy in Tim4 + Tumour‐Associated Macrophages. Journal of Cellular and Molecular Medicine. 2025;29(13). doi:10.1111/jcmm.70701
BibTeX
@article{Ni2025,
author = {Ni, Jiali and Li, Xiaoying and Wu, Yue and Tu, Xiaodi and Zhang, Xinxin and Wang, Lu and Xie, Hao and Hou, Yayi and Dou, Huan and Zhao, Shuli},
title = {CD81 Aggravates Ovarian Cancer Progression via p‐Cresyl Sulfate‐Mediated Mitophagy in Tim4 + Tumour‐Associated Macrophages},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
volume = {29},
number = {13},
doi = {10.1111/jcmm.70701}
}
EUVIMED